SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001615219-22-000063
Filing Date
2022-04-28
Accepted
2022-04-28 16:16:55
Documents
6
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 DEF 14A salarius-2022proxystatemen.htm DEF 14A 437550
2 image1a.jpg GRAPHIC 53495
3 image2a.jpg GRAPHIC 66897
4 image_0.jpg GRAPHIC 15020
5 image_1.jpg GRAPHIC 43236
6 imagea.jpg GRAPHIC 57504
  Complete submission text file 0001615219-22-000063.txt   764340
Mailing Address 2450 HOLCOMBE BLVD SUITE J-608 HOUSTON TX 77021
Business Address 2450 HOLCOMBE BLVD SUITE J-608 HOUSTON TX 77021 346-772-0346
Salarius Pharmaceuticals, Inc. (Filer) CIK: 0001615219 (see all company filings)

IRS No.: 465087339 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36812 | Film No.: 22866784
SIC: 2834 Pharmaceutical Preparations